Dare Bioscience DARE
NASDAQ DARE
$0.69 +0.00 (+0.16%)
As of: Oct 21, 2026 · 2:51 PM EDT

Dare Bioscience (DARE) Other financing activities (2014 - 2015)

Updated

Dare Bioscience (DARE) recorded Other financing activities of $321,686 in FY2025, up 305.6% from $79,308 in FY2024.

Analysis

Dare Bioscience (DARE) Other financing activities (2014 - 2015) Analysis & Trends

Starting with FY2012, Dare Bioscience's Other financing activities history includes 7 years.

  • Per Business Quant data, DARE's Other financing activities was $79,308 in FY2024 (-98.3%) and $4.72 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn
10 Dare Bioscience 10.28 Mn -55.19 Mn -132,343.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 19,000.00
Mar 31, 2015 -378,000.00
Dec 31, 2014 -34,000.00
Sep 30, 2014 -9,000.00
Jun 30, 2014 886,000.00
Mar 31, 2014 -1.07 Mn
API Access

Dare Bioscience Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=DARE&period=max&api_key=YOUR_API_KEY